Ani Pharmaceuticals (ANIP) Change in Inventory (2012 - 2026)

Ani Pharmaceuticals has disclosed Change in Inventory across 15 years of filings, most recently posting -$305000.0 for Q2 2026.

• In Q2 2026, Change in Inventory fell 133.59% year-over-year to -$305000.0; the TTM figure through Jun 2026 stood at $4.6 million (down 46.78% YoY), while the FY2025 annual figure was $6.0 million, down 72.0% from the prior year.
• Change in Inventory came in at -$305000.0 for Q2 2026 at Ani Pharmaceuticals, down from $437000.0 in the prior quarter.
• In the past five years, Change in Inventory ranged from a high of $11.6 million in Q2 2024 to a low of -$3.7 million in Q4 2025.
• Average Change in Inventory over 5 years is $3.2 million, with a median of $1.9 million recorded in 2022.
• Year-over-year, Change in Inventory soared 1635.58% in 2024 and tumbled 652.89% in 2025.
• Over 5 years, Change in Inventory stood at $9.5 million in 2022, then tumbled by 51.33% to $4.6 million in 2023, then slumped by 85.34% to $675000.0 in 2024, then plunged by 652.89% to -$3.7 million in 2025, then surged by 91.83% to -$305000.0 in 2026.
• Per Business Quant data, the three most recent Change in Inventory figures were -$305000.0 in Q2 2026, $437000.0 in Q1 2026, and -$3.7 million in Q4 2025.